Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy

European Journal of Medical Genetics

Volumn 53, Issue 5, 2010, Pages 261-267

  Millat, Gilles ^a,b   Bouvagnet, Patrice ^a,b   Chevalier, Philippe ^b,c   Dauphin, Claire ^d   Simon Jouk, Pierre ^e   Da Costa, Antoine ^f   Prieur, Fabienne ^g   Bresson, Jean Luc ^h   Faivre, Laurence ⁱ   Eicher, Jean Christophe ^j   Chassaing, Nicolas ^k   Crehalet, Hervé ^a,b   Porcher, Raphael ^l   Rodriguez Lafrasse, Claire ^a,b   Rousson, Robert ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL NORD   (France)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h HÔPITAL SAINT JACQUES   (France)

ⁱ Medical University of Dijon   (France)

^j DIJON UNIVERSITY HOSPITAL   (France)

^k TOULOUSE UNIVERSITY HOSPITAL   (France)

^l SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Genetic modifiers; Genetic screening; Hypertrophic cardiomyopathy; Molecular diagnosis; Mutations

Indexed keywords

MYOSIN BINDING PROTEIN C; TROPONIN I; TROPONIN T;

ADULT; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; SEQUENCE ANALYSIS;

EID: 77956941980     PISSN: 17697212     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmg.2010.07.007     Document Type: Article

References (22)

1. Aoki S., Mukae S., Itoh S., Sato R., Nishio K., Ueda H., Iwata T., Katagiri T. Genetic background in patients with acute myocardial infarction. Jpn. Heart J. 2001, 42:15-28.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a new and powerful approach to multiple testing. J. Royal Stat. Soc. Series. B. Stat. Methodol. 1995, 57:289-300.
3. Bos J.M., Ommen S.R., Ackerman M.J. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?. Curr. Opin. Cardiol. 2007, 22:193-199.
4. Charron P., Dubourg O., Desnos M., Bennaceur M., Carrier L., Camproux A.C., Isnard R., Hagege A., Langlard J.M., Bonne G., Richard P., Hainque B., Bouhour J.B., Schwartz K., Komajda M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998, 97:2230-2236.
5. Ehlermann P., Weichenhan D., Zehelein J., Steen H., Pribe R., Zeller R., Lehrke S., Zugck C., Ivandic B.T., Katus H.A. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene. BMC Med. Genet. 2008, 9:95.
6. Erdmann J., Daehmlow S., Wischke S., Senyuva M., Werner U., Raible J., Tanis N., Dyachenko S., Hummel M., Hetzer R., Regitz-Zagrosek V. Clin. Genet. 2003, 64:339-349.
7. Ingles J., Doolan A., Chiu C., Seidman J., Seidman C., Semsarian C. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J. Med. Genet. 2005, 42. e59.
8. Kaufman B.D., Auerbach S., Reddy S., Manlhiot C., Deng L., Prakash A., Printz B.F., Gruber D., Papavassiliou D.P., Hsu D.T., Sehnert A.J., Chung W.K., Mital S. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum. Genet. 2007, 122:515-523.
9. Kupari M., Hautanen A., Lankinen L., Koskinen P., Virolainen J., Nikkila H., White P.C. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998, 97:569-575.
10. Marian A.J. Genetic determinants of cardiac hypertrophy. Curr. Opin. Cardiol. 2008, 23:199-205.
11. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995, 92:785-789.
12. Morita H., Larson M.G., Barr S.C., Vasan R.S., O'Donnell C.J., Hirschhorn J.N., Levy D., Corey D., Seidman C.E., Seidman J.G., Benjamin E.J. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham heart study. Circulation 2006, 113:2697-2705.
13. Niimura H., Bachinski L.L., Sangwatanaroj S., Watkins H., Chudley A.E., McKenna W., Kristinsson A., Roberts R., Sole M., Maron B.J., Seidman J.G., Seidman C.E. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 1998, 338:1248-1257.
14. Olivotto I., Girolami F., Ackerman M.J., Nistri S., Bos J.M., Zachara E., Ommen S.R., Theis J.L., Vaubel R.A., Re F., Armentano C., Poggesi C., Torricelli F., Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin. Proc. 2008, 83:630-638.
15. Ortlepp J.R., Vosberg H.P., Reith S., Ohme F., Mahon N.G., Schröder D., Klues H.G., Hanrath P., McKenna W.J. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002, 87:270-275.
16. Patel R., Lim D.S., Reddy D., Nagueh S.F., Lutucuta S., Sole M.J., Zoghbi W.A., Quiñones M.A., Roberts R., Marian A.J. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2000, 32:2369-2377.
17. Perkins M.J., Van Driest S.L., Ellsworth E.G., Will M.L., Gersh B.J., Ommen S.R., Ackerman M.J. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur. Heart J. 2005, 26:2457-2462.
18. Pfeufer A., Osterziel K.J., Urata H., Borck G., Schuster H., Wienker T., Dietz R., Luft F.C. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am. J. Cardiol. 1996, 78:362-364.
19. Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.P., Millaire A., Desnos M., Schwartz K., Hainque B., Komajda M. Hypertrophic cardiomyopathy distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003, 107:2227-2232. for the EUROGENE Heart Failure Project Circulation.
20. Van Driest S.L., Ellsworth E.G., Ommen S.R., Tajik A.J., Gersh B.J., Ackerman M.J. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003, 108:445-451.
21. Van Driest S.L., Jaeger M.A., Ommen S.R., Will M.L., Gersh B.J., Tajik A.J., Ackerman M.J. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2004, 44:602-610.
22. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Tajik A.J., Gersh B.J., Ackerman M.J. Myosin binding protein c mutations and compound heterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2004, 44:1903-1910.